Feedback / Questions
SPX-303 - SparX
https://www.prnewswire.com/news-releases/sparx-group-announces-first-patient-dosed-with-spx-303-injection-the-first-in-its-class-of-anti-lilrb2pd-l1-bispecific-antibody-drugs-302114821.html
Apr 11, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next